US$ 21.56
types of glp-1 receptor agonists GLP-1 Receptor Agonists as Treatments
Description
Studies have linked GLP-1 medications to various eye conditions, some of which may lead to vision loss

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), initially developed for diabetes and obesity, exhibit pleiotropic effectsincluding anti-inflammatory, ...

Preclinical studies have confirmed that GIPRGLP1R coagonists improve several hallmarks of metabolic syndrome, such as obesity, hyperglycemia, and dyslipidemia

ICD-10 codes to identify the outcome are included in supplementary table S1

The GLP-1 market is expected to hit $200 billion by 2031, according to a new study.

Patients have found compounded semaglutide to be a cheaper, accessible GLP-1, but health experts warn of risks tied to the non-FDA-approved drugs.
